Therefore, it was concluded that METTL3-mediated m6A modification as a potential mechanism through which the ABHD11-AS1 is stably overexpressed, and contributes to the progression of NSCLC [23]. The gene discussed is ABHD11; the disease is non-small cell lung carcinoma.